Actively Recruiting
Whole Body MRI in Oncology
Led by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Updated on 2025-03-30
1000
Participants Needed
3
Research Sites
413 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
CONDITIONS
Official Title
Whole Body MRI in Oncology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients eligible for WB-MRI according to clinical practice for lymphoma, advanced prostate cancer, advanced breast cancer, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or multiple myeloma.
- Male or female aged 18 years or older.
- Willing and able to give informed consent.
- Life expectancy greater than 3 months.
You will not qualify if you...
- Patients with MRI-unsafe prostheses or devices.
- Patients whose MRI tests are of poor quality, incomplete, or had to be stopped.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola
Bologna, BO, Italy, 40138
Actively Recruiting
2
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.
Meldola, FC, Italy, 47014
Actively Recruiting
3
IRCCS Istituto Europeo di Oncologia S.r.l.
Milan, MI, Italy, 20141
Not Yet Recruiting
Research Team
O
Oriana Nanni
CONTACT
B
Bernadette Vertogen
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here